Aimovig (Erenumab): Complete Guide to Uses, Dosing, Availability, and How to Find It in Stock
What Is Aimovig?
Aimovig (erenumab-aooe) is a prescription injectable medication used to prevent migraine headaches in adults. It belongs to a class of drugs called calcitonin gene-related peptide (CGRP) monoclonal antibodies — a category of biologics specifically engineered to target one of the key biological pathways involved in migraine. Unlike older migraine medications that were originally developed for other conditions (like blood pressure drugs or antidepressants), Aimovig was designed from the ground up with migraine prevention in mind. That distinction matters, and millions of patients who failed older preventive therapies have found meaningful relief with it.
Aimovig is FDA-approved specifically for the preventive treatment of migraine in adults. That means it's intended to reduce how often migraines happen — not to stop a migraine once it's already started. It's prescribed to people who experience episodic migraine (typically defined as fewer than 15 headache days per month) as well as chronic migraine (15 or more headache days per month, with at least 8 of those being migraines). Aimovig received FDA approval on May 17, 2018, making it the first CGRP monoclonal antibody ever approved anywhere in the world. That milestone alone speaks to how significant a development it was in headache medicine. It's indicated for adults 18 and older, and your neurologist or headache specialist is likely the most common prescriber, though many primary care and internal medicine physicians prescribe it as well.
As of now, Aimovig is available only as a brand-name medication — there is no FDA-approved generic version of erenumab. Because it's a biologic, any future lower-cost version would technically be called a "biosimilar" rather than a traditional generic. No erenumab biosimilars have been approved in the United States as of this writing, though the biologic patent landscape is evolving. Amgen and Novartis jointly developed Aimovig, and Amgen currently markets it in the US. Because it's a brand-only biologic, cost and insurance coverage can be significant concerns for patients — something we'll cover in detail below. If you're having trouble finding Aimovig, FindUrMeds can locate it at a pharmacy near you.
How Does Aimovig Work?
Aimovig works by blocking a molecule called calcitonin gene-related peptide, or CGRP. CGRP is a small protein that's released in large amounts during a migraine attack. It causes blood vessels around the brain to dilate, triggers inflammation in the meninges (the protective layers surrounding your brain), and amplifies pain signals — essentially acting like a biochemical alarm that your brain can't turn off. Aimovig is a monoclonal antibody, meaning it's a highly targeted protein designed to bind specifically to the CGRP receptor and block CGRP from attaching to it. Think of it like a lock-and-key system: CGRP is the key, the receptor is the lock, and Aimovig sits in the lock so the key can't get in. With that receptor blocked, the cascade of events that leads to migraine is interrupted before it fully starts.
Aimovig is delivered as a subcutaneous injection — a small shot just under the skin — once per month. The autoinjector pen is designed to be self-administered at home, usually in the upper arm, abdomen, or thigh. Because it's a large-molecule biologic, it can't be taken orally; stomach acid would break it down before it could reach the bloodstream. Most patients begin to notice a reduction in migraine frequency within the first 1 to 3 months of treatment, with many clinical trial participants seeing meaningful improvement by month 3. The medication has a half-life of approximately 28 days, which is why monthly dosing is effective — a single injection maintains therapeutic blood levels for roughly 4 weeks. In the STRIVE clinical trial, patients on Aimovig 70 mg experienced an average reduction of 3.2 migraine days per month compared to placebo, with benefits continuing to build over 6 months of treatment.
Available Doses of Aimovig
Aimovig is available in 2 FDA-approved strengths, both administered as a once-monthly subcutaneous injection:
- 70 mg/mL — The standard starting dose for most patients. Comes as a single-dose autoinjector pen.
- 140 mg/mL — A higher dose for patients who don't achieve adequate response at 70 mg. Administered as a single injection of the 140 mg pen, or as two consecutive 70 mg injections.
Key dosing notes:
- The 70 mg monthly dose is the most common starting dose recommended by prescribers.
- If 70 mg provides insufficient relief after 3 months, your doctor may increase the dose to 140 mg monthly.
- Both strengths require refrigeration (store at 36°F–46°F / 2°C–8°C). If needed, the pen can be stored at room temperature (up to 77°F) for up to 7 days.
- Do not shake the autoinjector pen.
- Remove from the refrigerator 30 minutes before injecting to bring it to room temperature — this reduces injection site discomfort.
Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.
Aimovig Findability Score
Aimovig Findability Score: 82 / 100
Our Findability Score is a proprietary metric that rates how easy it is to locate a specific medication in stock at a retail or specialty pharmacy in the United States. The scale runs from 1 to 100 — a score of 1 means the drug is extremely difficult to find (think acute shortage, heavily DEA-restricted, or rare specialty-only distribution), while a score of 100 means you can walk into virtually any pharmacy and it'll be on the shelf. The score is calculated using our live pharmacy search data across 15,000+ locations, combined with FDA shortage list status, manufacturer supply signals, ASHP Drug Shortage Database records, and our own Pharmacy Call Index — a measure of how many pharmacies our team typically needs to contact before locating a specific drug.
Aimovig scores an 82 out of 100, which places it in the "generally available but not universally stocked" category. Several factors drive this score. First, Aimovig is not a controlled substance, so there are no DEA quota restrictions limiting supply. Second, as of this writing, erenumab does not appear on the FDA Drug Shortage Database, meaning there are no active manufacturer-level supply disruptions. Third, Amgen has maintained relatively consistent production and distribution. The primary reason Aimovig doesn't score closer to 95–100 is that it's a refrigerated biologic injectable — a category that not every retail pharmacy location carries routinely. Smaller independent pharmacies and some chain locations without dedicated biologics storage may simply not stock it. Based on ASHP Drug Shortage Database records and our platform's own tracking, Aimovig has not experienced a clinically significant national shortage since its launch, though localized availability gaps occur regularly.
What does an 82 mean practically for you? It means that Aimovig is findable — but it may not be sitting on the shelf at the first pharmacy you call. Our platform's analysis of Aimovig availability found that approximately 68% of patients are able to locate their dose at the first or second pharmacy contacted, while the remaining 32% require 3 or more contacts. Without a service like FindUrMeds, patients contact an average of 7–12 pharmacies before finding a biologic injectable in stock. That's a lot of phone calls, hold times, and the frustration of being transferred between departments. The medication's refrigerated storage requirement means that pharmacies with lower biologic prescription volume may choose not to carry standing inventory, ordering instead on a per-patient basis — which can add 24–72 hours of lead time.
Our success rate for locating Aimovig specifically across our network is 94% — slightly above our platform-wide average of 92%. That's because the drug is commercially available, not shortage-listed, and distributed through major wholesale channels that supply the chain pharmacies in our network. Skip the pharmacy calls. FindUrMeds finds Aimovig for you.
Aimovig Pricing
Aimovig is one of the more expensive preventive migraine medications on the market, primarily because it's a brand-name biologic with no generic or biosimilar competition in the US. Here's what you can expect across different payment scenarios:
With Insurance
- Insured patients with commercial (private) health insurance typically pay a copay ranging from $0 to $50 per month, especially when using Amgen's copay assistance program.
- Medicare and Medicaid coverage varies significantly by plan. Part D plans may cover Aimovig, but formulary placement and tier status affect out-of-pocket costs. Some Medicare patients pay $50–$200+ per month depending on their plan's coverage gap and deductible status.
- Prior authorization is almost always required — your prescriber will need to document that you've tried and failed at least 2 other preventive migraine treatments before insurance will approve Aimovig in many cases.
Without Insurance (Cash Price)
- The list price (WAC) of Aimovig is approximately $700–$900 per month for the 70 mg dose and $800–$1,000 per month for 140 mg. These are rough list-price figures and actual retail cash prices may vary.
- Few patients pay list price. If you're uninsured, the options below significantly reduce your cost.
GoodRx Estimated Price
- GoodRx coupons can reduce the cash price of Aimovig to approximately $550–$750 per month at some pharmacies, though biologic discounts through GoodRx tend to be smaller in percentage terms than for small-molecule drugs. Prices vary significantly by pharmacy and region — always check GoodRx's live pricing tool for your specific zip code and preferred pharmacy.
Manufacturer Assistance Programs
- Aimovig Ally Program (Amgen): Commercial insurance patients may pay as little as $0–$5 per month through Amgen's copay card program. Eligibility requires commercial (non-government) insurance. Enroll at aimovig.com or call 1-833-AIMOVIG.
- Amgen Safety Net Foundation: For uninsured or underinsured patients who meet income requirements, Amgen may provide Aimovig at no cost. This is worth exploring if cost is a barrier.
- Patient Advocacy Organizations: Organizations like the American Migraine Foundation maintain lists of financial assistance resources for migraine patients.
Price Variability Note: Prices vary meaningfully by pharmacy chain, region, and whether a location participates in a given discount program. Always confirm the actual price at your specific pharmacy before filling. A FindUrMeds search can help you compare availability across multiple chains simultaneously.
Who Can Prescribe Aimovig?
Aimovig is a prescription medication, but it's not restricted to a single specialty. A wide range of licensed prescribers can write this prescription:
- Neurologists — The most common prescribers. Headache specialists (neurologists with additional fellowship training in headache medicine) are often the first to initiate Aimovig and are the preferred prescribers for complex migraine cases.
- Headache Specialists — Board-certified headache medicine physicians (typically neurologists or internists with headache subspecialty training). If you have chronic migraine, this is the ideal prescriber type.
- Primary Care Physicians (PCPs) / Family Medicine Doctors — Can and do prescribe Aimovig, particularly for patients with established migraine diagnoses. May refer complex cases to neurology first.
- Internal Medicine Physicians — Similar prescribing capacity to PCPs.
- Physician Assistants (PAs) and Nurse Practitioners (NPs) — In most US states, PAs and NPs have full or broad prescribing authority and can prescribe Aimovig independently or in collaboration with a physician.
- OB-GYN Physicians — May prescribe Aimovig for women whose migraines are linked to hormonal cycles, though this is less common and may involve collaboration with neurology.
Telemedicine Prescribing: Aimovig can be prescribed via telemedicine in most US states. Because it's not a controlled substance, there are no federal restrictions requiring in-person evaluation before prescribing. However, individual state telemedicine laws vary, and many headache specialists prefer at least one in-person visit before initiating a biologic. Telemedicine neurology platforms (such as Teladoc, Cerebral's neurology services, and others) do offer CGRP preventive prescribing in many states. If you're starting Aimovig, a telehealth consultation may be sufficient to get your prescription — though follow-up for injection training is worth considering.
Once you have your prescription, the harder problem is finding a pharmacy that has it. That's where FindUrMeds comes in.
Aimovig Side Effects
Aimovig is generally well-tolerated, with a favorable safety profile compared to older migraine preventives like topiramate, valproate, or amitriptyline. That said, no medication is side-effect-free. Here's what the clinical data and patient reports tell us.
Most Common Side Effects
These occurred in clinical trials at rates notably higher than placebo:
- Injection site reactions — Pain, redness, or swelling at the injection site. Reported by approximately 5–6% of patients. Usually mild and resolves within hours. Letting the pen come to room temperature before injecting helps.
- Constipation — One of the more clinically significant common side effects, affecting roughly 3–4% of patients at the 70 mg dose and up to 6% at 140 mg. CGRP plays a role in gut motility, so blocking its receptor can slow digestion. Staying well hydrated and increasing dietary fiber can help. Severe constipation (including rare cases requiring hospitalization) has been reported.
- Injection site bruising — Superficial bruising at the injection site. Minor and self-limiting.
- Muscle cramps or spasms — Reported by a small percentage of users, typically mild.
Less Common but Serious Side Effects
Contact your provider if you experience any of the following:
- Serious constipation or bowel obstruction — Contact your doctor immediately if you have not had a bowel movement in 3 or more days, experience significant abdominal pain, or develop nausea and vomiting alongside constipation. Rare but serious cases have occurred.
- Severe allergic reactions (hypersensitivity) — Including rash, hives, facial swelling, or difficulty breathing. Seek emergency medical care immediately. Anaphylaxis has been reported in post-marketing data, though it is rare.
- Hypertension — Some patients experience elevated blood pressure. If you have pre-existing hypertension or cardiovascular disease, your prescriber should monitor blood pressure during treatment.
- Hair loss (alopecia) — Reported in post-marketing surveillance. Not common in clinical trials but has been flagged by patients and some healthcare providers in real-world use. If you notice significant hair thinning, discuss with your doctor.
Side Effects That Typically Improve Over Time
Some patients experience mild fatigue or a brief injection-site discomfort in the first 1–2 months of treatment. These symptoms tend to lessen as the body adjusts to the medication. Constipation, if it develops, may require ongoing dietary management or over-the-counter support — it doesn't always resolve on its own. Most patients who experience injection site reactions find them much less bothersome by month 2 or 3 once they've developed a comfortable self-injection routine.
This information is for general educational purposes only. This does not constitute medical advice. Talk to your doctor or pharmacist about the full side effect profile and whether Aimovig is appropriate for your health history.
Alternatives to Aimovig
If Aimovig isn't the right fit — whether because of cost, availability, side effects, or treatment response — there are several alternatives worth discussing with your neurologist. The migraine prevention landscape has expanded significantly in recent years.
Same-Class Alternatives (CGRP Pathway)
These medications work through the same general biological mechanism as Aimovig — targeting the CGRP pathway — but differ in their specific molecular targets, dosing schedules, and administration routes:
- Ajovy (fremanezumab) — A CGRP monoclonal antibody (targeting CGRP itself rather than the receptor). Approved for episodic and chronic migraine prevention. Available as monthly (225 mg) or quarterly (675 mg) injections — the quarterly option is a significant lifestyle advantage for some patients.
- Emgality (galcanezumab) — Another anti-CGRP antibody with monthly subcutaneous dosing. Also FDA-approved for cluster headache prevention, which neither Aimovig nor Ajovy are. A 240 mg loading dose is used in the first month.
- Vyepti (eptinezumab) — The only IV-infused CGRP antibody for migraine prevention. Given as a 30-minute infusion every 3 months in a clinical setting. Appeals to patients who prefer not to self-inject, and some studies show faster onset of effect.
- Nurtec ODT (rimegepant) — preventive use — A small-molecule CGRP receptor antagonist (gepant) taken as an oral dissolving tablet every other day. Unique in that it's also FDA-approved as an acute treatment. Oral dosing is a major advantage over injectable CGRP antibodies.
- Qulipta (atogepant) — An oral gepant taken daily or every other day for episodic or chronic migraine prevention. Fully oral, no injections required.
Different-Mechanism Alternatives
For patients who need a fundamentally different approach — due to CGRP pathway failure, contraindications, or insurance restrictions:
- Topiramate (Topamax / Trokendi) — An anticonvulsant with robust evidence for migraine prevention. Less expensive, widely generic. Cognitive side effects ("brain fog") are common complaints.
- Valproate (Depakote) — Another anticonvulsant with migraine prevention indication. Significant teratogenicity risk — not appropriate for women of childbearing potential.
- Amitriptyline — A tricyclic antidepressant with decades of off-label use in migraine prevention. Very inexpensive and available generically.
- Propranolol / Metoprolol — Beta-blockers with FDA migraine prevention indications. Long safety track record, very low cost.
- Botulinum toxin (Botox) — FDA-approved for chronic migraine (15+ headache days/month). Administered as 31 injections across the head and neck every 12 weeks by a trained provider. Effective for many patients who've failed oral preventives.
If you'd prefer to stick with Aimovig, FindUrMeds has a high success rate finding it in stock.
Drug Interactions with Aimovig
One of the clinical advantages of monoclonal antibody therapies like Aimovig is their relatively limited drug interaction profile. Because Aimovig is a large-molecule biologic, it's not metabolized by the liver's cytochrome P450 enzyme system — the main pathway through which most small-molecule drug interactions occur. That said, interactions do exist and your full medication list should always be reviewed by your prescriber or pharmacist.
Serious Interactions
- Other biologic or immunosuppressive agents — Combining Aimovig with other monoclonal antibodies, immunosuppressants, or biologics (such as those used in rheumatoid arthritis or Crohn's disease) hasn't been extensively studied in combination. Your prescriber should carefully weigh risks of immunomodulation.
- Live vaccines — While not a direct pharmacological interaction, use caution with live-attenuated vaccines during biologic therapy. Discuss timing of any vaccinations (including shingles vaccine Zostavax, if live) with your doctor.
Moderate Interactions
- Triptans (sumatriptan, rizatriptan, etc.) — Aimovig is a preventive, and triptans are acute treatments. They can be used together, but overuse of triptans (more than 10 days/month) can cause medication overuse headache (MOH), which may reduce Aimovig's effectiveness. Your neurologist will likely set triptan usage guidelines.
- Ergotamine derivatives — Similar caution applies. Overuse can contribute to MOH and interfere with preventive efficacy.
- Antihypertensive medications — Since Aimovig may affect blood pressure in some patients, those on antihypertensives should monitor blood pressure more frequently when starting Aimovig.
- Opioids and barbiturate-containing medications — These carry high MOH risk and may reduce the effectiveness of any migraine preventive, including Aimovig.
Food and Substance Interactions
- Caffeine — No direct pharmacokinetic interaction, but caffeine is a well-documented migraine trigger and can contribute to medication overuse headache. Your headache specialist may recommend limiting caffeine intake while on Aimovig to maximize treatment response.
- Alcohol — No known direct interaction with erenumab, but alcohol is a common migraine trigger. Reducing alcohol consumption may improve outcomes.
- Grapefruit — Not a relevant concern for Aimovig. Because it's not metabolized by CYP3A4, grapefruit and grapefruit juice have no meaningful effect on erenumab blood levels.
- Aspartame and certain food additives — Not pharmacological interactions with Aimovig, but some migraine patients identify these as personal triggers. Worth tracking in a headache diary.
How to Find Aimovig in Stock
Finding Aimovig is the part where many patients hit a wall. Your prescription is in hand, but the pharmacy says they're out of stock, or they "don't usually carry that one," or they can order it but it'll take 3–5 business days. Here's a practical, step-by-step guide to getting your Aimovig faster.
1. Use FindUrMeds — The Fastest Option
FindUrMeds exists precisely for this problem. Here's how it works:
- Submit your request online in under 2 minutes. Provide your medication name, dose, and zip code. No account creation or insurance information required to start a search.
- Our team contacts pharmacies on your behalf. We reach out across our network of 15,000+ pharmacy locations — including CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, and Sam's Club — to find Aimovig in stock in your area. We ask about both the 70 mg and 140 mg strengths simultaneously.
- You get a confirmed location within 24–48 hours. We tell you exactly which pharmacy has your medication, so you can call ahead or go directly. No guesswork. No hold music. No transferring between departments.
Our Pharmacy Call Index for Aimovig shows that unassisted patients contact an average of 7–12 pharmacies before locating their dose. FindUrMeds reduces that to zero calls on your end.
2. Check GoodRx — The Price-Listing-Signals-Stock Hack
GoodRx isn't just for discounts — it can also signal which pharmacies are actively filling a prescription. Here's the trick:
- Go to GoodRx.com and search for Aimovig.
- Enter your zip code and look at the price listings across different pharmacies.
- Pharmacies showing specific cash prices (rather than "call for price" or no price at all) are more likely to have the drug in their inventory system and actively dispensing it.
- Pharmacies listed as "not available" or showing no price are often out of stock or don't carry it.
- Once you identify pharmacies with a listed price, call to confirm stock before driving over. GoodRx pricing data updates periodically but isn't real-time.
This isn't foolproof, but it narrows your list significantly before you pick up the phone.
3. Check Pharmacy Apps and Websites
Major chain pharmacy apps allow some level of medication search or transfer request that can reveal availability:
- CVS app / CVS.com: Use the prescription transfer feature or specialty pharmacy search. CVS Specialty handles many biologic prescriptions and may have standing stock even when retail locations don't. Call 1-800-CVS-CARE and specifically ask about their specialty pharmacy locations.
- Walgreens app: Similar functionality. Walgreens has a specialty pharmacy division (Walgreens Specialty Pharmacy) that may carry Aimovig even when local retail branches don't.
- Walmart Pharmacy: Walmart's pharmacy app allows you to check which locations carry specific medications in some cases. Walmart pharmacies in larger stores tend to have more biologic inventory than smaller locations.
- Costco Pharmacy: Costco pharmacies often have competitive pricing on biologics and may carry Aimovig. Membership is required for most services, but pharmacy services are technically available to non-members in some states (California, Michigan, and a few others).
Tip: When using pharmacy apps, if you can't find Aimovig specifically, try searching for "erenumab" — some systems catalog medications by generic name in their internal databases.
4. Call with the Generic Name — Use This Exact Script
Many pharmacy staff are more likely to correctly locate a biologic when you use the generic name. Some technicians may not immediately recognize brand names in their inventory system. Here's a simple, effective phone script:
"Hi, I'm looking for erenumab — it's also called Aimovig. Do you currently have it in stock in any strength, either 70 milligrams or 140 milligrams? I just want to confirm before I transfer my prescription."
A few tips for the call:
- Call during off-peak hours (mid-morning on weekdays, avoiding lunch rush and evenings) when pharmacy staff have more time to check inventory thoroughly.
- Ask specifically if they can confirm on-hand stock, not just "if they carry it" — a pharmacy may "carry" a drug but be temporarily out.
- If they're out, ask when the next shipment is expected and whether they can place a special order.
- Ask if their specialty pharmacy location (if it's a chain) might have it in stock, even if that location requires shipping to your home.
🔵 Ready to skip all of this?
FindUrMeds does it for you. We contact pharmacies across 15,000+ locations and find your Aimovig in stock — usually within 24–48 hours.
No phone calls. No hold music. No driving to a pharmacy that's out of stock.
Frequently Asked Questions
Is Aimovig still in shortage?
As of this writing, Aimovig (erenumab) does not appear on the FDA Drug Shortage Database, and there are no active manufacturer-level supply disruptions reported in the ASHP Drug Shortage Database. Amgen has maintained consistent production since the drug's 2018 launch. However, localized availability gaps are common — particularly at smaller retail pharmacies that don't carry standing biologic inventory. "Not in stock at your local pharmacy" and "national shortage" are very different things. According to our data across thousands of Aimovig pharmacy searches, approximately 94% of patients who use FindUrMeds are able to locate Aimovig in stock within 24–48 hours. If you're hitting a local wall, the drug is almost certainly available — it just may be at a different pharmacy in your area, or through a specialty pharmacy.
How much does Aimovig cost without insurance?
Without insurance, Aimovig is expensive. The retail list price is approximately $700–$900 per month for the 70 mg dose. GoodRx coupons may bring this down to approximately $550–$750 per month depending on your location and pharmacy. However, if you have commercial insurance and use Amgen's copay card through the Aimovig Ally Program, your cost may be as low as $0–$5 per month. If you're uninsured and cost is a barrier, the Amgen Safety Net Foundation offers free Aimovig to eligible patients based on income. Contact Amgen directly at 1-833-AIMOVIG or visit aimovig.com for current assistance program details — these programs change, and speaking to a patient support representative will give you the most accurate current information.
Can I get Aimovig through mail order?
Yes, and for many patients this is actually the most reliable way to get Aimovig. Mail-order and specialty pharmacy delivery is well-suited to Aimovig because the medication requires refrigeration and is not universally stocked at retail locations. Major specialty pharmacies — including CVS Specialty, Walgreens Specialty, Accredo (part of Express Scripts), and Optum Rx — routinely dispense Aimovig with proper cold-chain shipping to your home. Many insurance plans actually require specialty pharmacy fulfillment for biologic medications, so check your plan documents or call your insurance's pharmacy benefits number. Your prescriber can send the prescription directly to a specialty pharmacy. Mail order typically means a 90-day supply (3 months of injections) shipped at once, which many patients prefer for convenience.
What's the difference between Aimovig and Ajovy?
Aimovig (erenumab) and Ajovy (fremanezumab) are both CGRP monoclonal antibodies approved for migraine prevention, but they work at slightly different points in the same pathway. Aimovig targets and blocks the CGRP receptor — the docking site on cells that CGRP binds to. Ajovy targets CGRP itself — the molecule before it ever reaches the receptor. In practice, both approaches are effective, and head-to-head efficacy data comparing the two directly is limited. The most clinically relevant difference for many patients is dosing flexibility: Ajovy offers both a monthly injection (225 mg) and a quarterly injection (675 mg) option, while Aimovig is monthly only. Patients who struggle with monthly injection adherence sometimes prefer Ajovy's quarterly dosing. Side effect profiles are broadly similar, though individual patient responses vary. Your neurologist is the best person to help you decide which agent fits your situation.
What if my pharmacy is out of Aimovig?
First, don't panic — being out of stock at one pharmacy doesn't mean you can't find it. Here are your best next steps: Ask your pharmacy if they can place a special order and when it would arrive (typically 1–3 business days). Call other nearby locations of the same chain, since inventory varies by individual store. Ask your prescriber to send the prescription to a specialty pharmacy that ships to your home. Use FindUrMeds — our team contacts pharmacies across 15,000+ locations and typically locates Aimovig within 24–48 hours. If you're approaching the end of your dosing window, let your prescriber know — in some cases, a short bridge or adjusted timing may be appropriate while you secure your next supply. Because Aimovig has a half-life of approximately 28 days, a delay of a few days is unlikely to cause dramatic change in your migraine pattern, but don't delay longer than necessary.
Need help finding Aimovig in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.
FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.
About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →